Published 3 days ago • loading... • Updated 3 days ago

Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of ...

RAD101 PET demonstrated 93% concordance with MRI across all evaluable lesions, meeting the trial's primary endpoint.

RAD101 PET demonstrated 93% concordance with MRI across all evaluable lesions, meeting the trial's primary endpoint.

3 days ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left1Leaning Right0Center0Last Updated3 days agoBias Distribution

100% Left

100% Left

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Enid News & Eagle broke the news 3 days ago on Wednesday, July 22, 2026.

Sources are mostly out of (0)